In order to maintain a high vertical range of manufacturing within the company and to be as independent as possible from external influences, it is worthwhile setting up your own additive manufacturing production cells worldwide. Thanks to complete networking and the integration of digital intelligence, distributed production on a global level is created.
Like many other industries, medical technology has shifted the production of components or entire products to locations with low labor costs. The weaknesses of this strategy become apparent in times of a pandemic, as sometimes drastic supply bottlenecks can occur. The solution:
It is important for the future that this strategy is pursued not only in a concrete emergency, but also on a long-term basis.What does that look like in concrete terms? Read our showcase on the production of swabs for corona test kits in Australia, Canada and Spain.
Thank you for your message.